This scientific essay will deal with the topics of the module Business Ethics. The term will be described further in the following chapters, especially in chapter 2.2. This paper will describe, explain, and assess how the coronavirus pandemic of 2019 has shaped the world in the areas of ethical and responsibility challenges and opportunities, on the example of the German pharmaceutical company Bayer AG.
Firstly, the core concepts are described and elaborated in the following. Secondly, the pandemic and its impacts based on the Triple Bottom Line are outlined. Lastly, the paper will deal with a case study on the example of the Bayer AG. The main questions in this connection are: How does the Bayer AG react onto the pandemic on an ethical and responsibility base? How did the behaviour of the company change due to the pandemic? What was the reaction of the public onto the company’s performance, especially the effect on its reputation?
Inhaltsverzeichnis (Table of Contents)
- 1 Introduction
- 2 Main Concepts
- 2.1 Triple Bottom Line
- 2.2 Business Ethics
- 2.3 Corporate Social Responsibility
- 3 Coronavirus Pandemic
- 3.1 Social Impact
- 3.2 Environmental Impact
- 3.3 Economical Impact
- 4 Health System and Medical Research
- 4.1 Ethical Decisions
- 4.2 Pharmaceutical Sector
- 5 Case Study: Bayer AG
- 5.1 Ethical and Responsibility Reaction
- 5.2 Change in Behaviour
- 5.3 Company's Reputation and Consequences
Zielsetzung und Themenschwerpunkte (Objectives and Key Themes)
This scientific essay focuses on the ethical and responsibility challenges and opportunities arising from the COVID-19 crisis, specifically examining the pharmaceutical sector through the lens of the Bayer AG. The essay aims to analyze the impact of the pandemic on the Bayer AG, considering the company's ethical and responsible responses, changes in behavior, and the subsequent effects on its reputation.
- Ethical and responsibility challenges and opportunities during the COVID-19 crisis
- The role of the pharmaceutical sector in the pandemic
- The Triple Bottom Line framework and its application to the Bayer AG
- The impact of the pandemic on the company's reputation and behavior
- The ethical and responsible response of the Bayer AG to the pandemic
Zusammenfassung der Kapitel (Chapter Summaries)
The essay commences with an introduction, providing a brief overview of the topic and outlining the key questions addressed in the following chapters. Chapter 2 delves into the core concepts: the Triple Bottom Line, Business Ethics, and Corporate Social Responsibility. These concepts serve as a foundation for understanding the ethical and responsible considerations surrounding the COVID-19 crisis.
Chapter 3 explores the impact of the pandemic on the world, analyzing the social, environmental, and economic consequences based on the Triple Bottom Line framework. Chapter 4 focuses on the health system and medical research, particularly addressing the ethical decisions involved in the pharmaceutical sector during the crisis.
Chapter 5 presents a case study on the Bayer AG, examining the company's ethical and responsible reaction to the pandemic, changes in behavior, and the subsequent impact on its reputation.
Schlüsselwörter (Keywords)
The primary keywords and focus topics of this essay include: COVID-19 crisis, pharmaceutical sector, Bayer AG, ethical and responsible behavior, Triple Bottom Line, Corporate Social Responsibility, reputation management, and pandemic impact.
- Quote paper
- Tim Niklas Buchholz (Author), 2020, Ethical and Responsibility Challenges and Opportunities arising from the COVID-19 Crisis. Focusing on the Pharmaceutical Sector the Example of the Bayer AG, Munich, GRIN Verlag, https://www.grin.com/document/1005611
